... s, also known as immunosuppressive agents, immunosuppressants and antirejection medications, are drugs ... Actual or suspected immunosuppressive agents can be evaluated in terms of their effects on lymphocyte subpopulations in tissues ... Immunosuppressive+Agents at the U.S. National Library of Medicine Medical Subject Headings (MeSH) (Articles with short ... Gillett NA, Chan C (April 2000). "Applications of immunohistochemistry in the evaluation of immunosuppressive agents". Human & ...
ISBN 978-3-642-99941-3. Alan C. Sartorelli; David G. Johns (27 November 2013). Antineoplastic and Immunosuppressive Agents. ... Antineoplastic and Immunosuppressive Agents. pp. 170-192. doi:10.1007/978-3-642-65806-8_11. ISBN 978-3-642-65806-8. Halogenated ... Carpenter JT (1988). "Progestational agents in the treatment of breast cancer". Cancer Treat. Res. Cancer Treatment and ...
Antineoplastic and Immunosuppressive Agents. pp. 170-192. doi:10.1007/978-3-642-65806-8_11. ISBN 978-3-642-65806-8. Nathanson ... 549-. ISBN 978-3-642-30725-6. The first sex steroid used as pharmacological agent was Progynon, first sold by Schering AG in ...
Sartorelli AC, Johns DG (27 November 2013). Antineoplastic and Immunosuppressive Agents. Springer Science & Business Media. pp ...
31-. ISBN 978-1-4613-2157-6. Sartorelli AC, Johns DG (27 November 2013). Antineoplastic and Immunosuppressive Agents. Springer ...
83-. ISBN 978-1-4832-7299-3. Alan C. Sartorelli; David G. Johns (27 November 2013). Antineoplastic and Immunosuppressive Agents ...
Sartorelli, Alan C.; Johns, David G. (27 November 2013). Antineoplastic and Immunosuppressive Agents. Springer Science & ... Anthramycin is an active anti-tumor agent and antibiotic. It works by inhibiting the synthesis of RNA and DNA of carcinoma ...
Antineoplastic and Immunosuppressive Agents. pp. 170-192. doi:10.1007/978-3-642-65806-8_11. ISBN 978-3-642-65806-8. Archived ... Geller J, Fruchtman B, Newman H, Roberts T, Silva R (February 1967). "Effect of progestational agents on carcinoma of the ... Hall NR (June 2011). "What agent should be used to prevent recurrent preterm birth: 17-P or natural progesterone?". Obstetrics ... In the group of new parenteral progestational agents, three substances developed by Karl Junkmann1,2 are the most outstanding ...
Antineoplastic and Immunosuppressive Agents. pp. 170-192. doi:10.1007/978-3-642-65806-8_11. ISBN 978-3-642-65806-8. ...
Antineoplastic and Immunosuppressive Agents. pp. 170-192. doi:10.1007/978-3-642-65806-8_11. ISBN 978-3-642-65806-8. Oxylone ... ISBN 978-3-88763-075-1. Morton IK, Hall JM (6 December 2012). Concise Dictionary of Pharmacological Agents: Properties and ...
Antineoplastic and Immunosuppressive Agents. pp. 170-192. doi:10.1007/978-3-642-65806-8_11. ISBN 978-3-642-65806-8. Council on ... However, androstanolone is nonetheless described as a very poor anabolic agent. This is attributed to its high affinity as a ... von Deutsch DA, Abukhalaf IK, Lapu-Bula R (15 October 2003). "Anabolic Doping Agents". In Mozayani A, Raymon L (eds.). Handbook ... 63-. ISBN 978-3-88763-075-1. Morton IK, Hall JM (6 December 2012). Concise Dictionary of Pharmacological Agents: Properties and ...
ISBN 978-0-323-13916-8. Alan C. Sartorelli; David G. Johns (27 November 2013). Antineoplastic and Immunosuppressive Agents. ...
Antineoplastic and Immunosuppressive Agents. pp. 170-192. doi:10.1007/978-3-642-65806-8_11. ISBN 978-3-642-65806-8. Li JJ (3 ... 219-. ISBN 978-3-88763-075-1. Morton IK, Hall JM (6 December 2012). Concise Dictionary of Pharmacological Agents: Properties ...
Antineoplastic and Immunosuppressive Agents. pp. 170-192. doi:10.1007/978-3-642-65806-8_11. ISBN 978-3-642-65806-8. v t e v t e ...
31-. ISBN 978-1-4613-2157-6. Sartorelli AC, Johns DG (27 November 2013). Antineoplastic and Immunosuppressive Agents. Springer ... Morton IK, Hall JM (6 December 2012). Concise Dictionary of Pharmacological Agents: Properties and Synonyms. Springer Science ...
Antineoplastic and Immunosuppressive Agents. Springer Science & Business Media. pp. 181-. ISBN 978-3-642-65806-8. Heinrich Kahr ...
Antineoplastic and Immunosuppressive Agents part 2. Springer Science & Business Media. ISBN 978-3-642-65806-8. Hatano, K. (2003 ...
Kay, AB (May 1994). "Immunosuppressive agents in chronic severe asthma". Allergy Proc. 15 (3): 147-50. doi:10.2500/ ... It was originally used to prevent transplant rejection of solid organs but has also found use as an orally administered agent ... Ciclosporin has been touted as a therapeutic option in moderate to severe asthmatic patients as a corticosteroid sparing agent ... Evans, DJ; Cullinan, P; Geddes, DM (2001). "Cyclosporin as an oral corticosteroid sparing agent in stable asthma". Cochrane ...
Severe cases require administration of systemic immunosuppressive agents. The more commonly used drugs are cyclosporine A, ... Several case reports showed that biological agents, such as anti-tumor necrosis factor alpha (anti-TNF) or monoclonal ...
Prednisone is an immunosuppressive agent which affects all of the organ systems. Effects on the cellular level include cell ... Ciclosporin is an immunosuppressive agent most often used in organ transplantation that has demonstrated to be effective with ... Immunosuppressive agents are administered in attempt to decrease blistering; this is not often effective. The first medication ... This is followed by steroid sparing agents which may reduce steroid intake and therefore lessen the side effects. Skin lesions ...
Another treatment option is a steroid-sparing immunosuppressive agent. This also works to weaken the immune system, but does ... Benign acute childhood myositis has been described in children after prodromal viral infections with different viral agents. ...
... and has introduced cyclosporin as an effective immunosuppressive agent." Forrest's award was made "in recognition of his ...
Q. Ashton Acton (2012). Immunosuppressive Agents-Advances in Research and Application: 2012 Edition. ScholarlyEditions. ISBN ...
... selective IMPDH inhibitor and immunosuppressive agent". Journal of Pharmaceutical Sciences. 90 (5): 625-37. doi:10.1002/1520- ... Arunachalam R, Kumar P M U (10 July 2020). "COVID-19: Clinical Trials and Potential Therapeutic Agents - A Narrative Review". ... This consequently inhibits synthesis of DNA and RNA, and results in antiviral and immunosuppressive effects. It progressed as ...
azathioprine (Imuran), the first immunosuppressive agent, used for organ transplants. allopurinol (Zyloprim), for gout. ...
... azathioprine and other drugs are used as immunosuppressive agents. A hot spot, or acute moist dermatitis, is an acutely ...
Treatment included corticosteroids and immunosuppressive agents, which affect heart function.[citation needed] At an event ... who claimed he was her agent. Callas was photographed with her mouth turned in a furious snarl. The photo was sent around the ... insinuated herself into Callas's trust during her last years and acted virtually as her agent. This claim is corroborated by ...
A history of topical steroid or immunosuppressive agent is noted. Confirmation is with a skin scraping and either fungal ... The removal of the offending topical steroid or immunosuppressive agent and treatment with a topical antifungal is often ...
Sugiyama, S.; Arai, S.; Kiriyama, M.; Ishii, K. (2005). "A convenient synthesis of immunosuppressive agent FTY720 using the ... a potent immunosuppressive agent. Petasis and coworkers reported the usage of unprotected carbohydrates as the carbonyl ... Reported in 1993 by Nicos Petasis as a practical method towards the synthesis of a geometrically pure antifungal agent, ... Racemic Clopidogrel, an antiplatelet agent, was synthesized in two steps using Petasis reaction. The Petasis reaction exhibits ...
Response to corticosteroid treatment and immunosuppressive agents also support this idea. Trauma has also been seen to precede ... cytotoxic agents (chlorambucil, cyclophosphamide), corticosteroid sparing immunosuppressants (methotrexate, cyclosporine, ...